Importance of methicillin-resistant Staphylococcus aureus eradication in carriers to prevent postoperative methicillin-resistant Staphylococcus aureus surgical site infection

American Surgeon

Volumn 77, Issue 1, 2011, Pages 27-31

  Pofahl, Walter E ^a   Ramsey, Keith M ^a   Nobles, Delores L ^b   Cochran, M Kathy ^b   Goettler, Claudia ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b PITT COUNTY MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; PSEUDOMONIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; ERADICATION THERAPY; HUMAN; INFECTION RISK; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NOSE SMEAR; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; SCREENING TEST; SURGICAL INFECTION; TERTIARY HEALTH CARE;

ADMINISTRATION, INTRANASAL; AGED; ANTI-BACTERIAL AGENTS; CARRIER STATE; COHORT STUDIES; FEMALE; HUMANS; MALE; MASS SCREENING; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MUPIROCIN; NASAL CAVITY; PREOPERATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL INFECTIONS; SURGICAL WOUND INFECTION; TREATMENT OUTCOME;

EID: 78651353217     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Keuhnert MJ, Kruszon-Moran D, Hill HA, et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis 2006;193:172-9.
2. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007;298:1763-71. (Pubitemid 47598444)
3. Pofahl WE, Goettler CE, Ramsey KM. Active surveillance screening of MRSA and eradication of the carrier state decreases surgical site infections caused by MRSA. J Am Coll Surg 2009;208:981-8.
4. Yano K, Minoda Y, Sakawa A, et al. Positive nasal culture of methicillin-resistant Staphylococcus aureus (MRSA) is a risk factor for surgical site infection in orthopedics. Acta Orthop 2009;80:486-90.
5. Shukla S, Nixon M, Acharya M, et al. Incidence of MRSA surgical-site infection in MRSA carriers in an orthopaedic trauma unit. J Bone Joint Surg 2009;91:225-8.
6. Cowie SE, Ma I, Lee SK, et al. Nosocomial MRSA in vascular surgery patients: impact on patient outcome. Vasc Endovascular Surg 2005;39:327-34. (Pubitemid 41061699)
7. Lamb YJ. Overview of the role of mupirocin. J Hosp Infect 1991;19(suppl B):27-30.
8. Robiscek A, Beaumont JL, Paile SM, et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 2008;148:409-18.
9. Horan TC, Gaynes RP, Martone WJ, et al. CDC definitions of nosocomial surgical site infections, 1992; a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992;13:606-8.
10. Paule SM, Hacek DM, Kufner B. Performance of the BD GeneOhm methicillin-resistant Staphylococcus aureus test before and during high volume clinical use. J Clin Microbiol 2007;45:2993-8. (Pubitemid 47417345)
11. Wilcox MH, Hall J, Pike H, et al. Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections. J Hosp Infect 2003;54:196-201. (Pubitemid 38001992)
12. Coa JE, Duckworth GJ, Edwards DI, et al. Guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect 2006;63(Suppl 1):S1-44.
13. Perl TM, Cullen JJ, Wenzel RP, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 2002;346:1871-7.
14. Kallen AJ, Wilson DT, Larson RJ. Perioperative intranasal mupirocin for the prevention of surgical-site infections: systematic review of the literature and meta-analysis. Infect Control Hosp Epidemiol 2005;26:916-22.
15. Schelenz S, Tucker D, Georgeu C, et al. Significant reduction of endemic MRSA acquisition and infection in cardiothoracic patients by means of an enhanced targeted infection control programme. J Hosp Infect 2005;60:104-10. (Pubitemid 40590576)
16. Jones JJ, Rogers TJ, Brookmeyer P, et al. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Clin Infect Dis 2007;45:541-7. (Pubitemid 47328632)
17. Bode LGM, Kluytmans JAJW, Wertheim HFL, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010;362:9-17.
18. Graf K, Sohr D, Haverich A, et al. Decrease of deep sternal surgical site infection rates after cardiac surgery by a comprehensive infection control program. Interact Cardiovasc Thorac Surg 2009;9:282-6.
19. Awad SS, Palacio CH, Subramanian A, et al. Implementation of a methicillin-resistant Staphylococcus aureus (MRSA) prevention bundle results in decreased MRSA surgical site infections. Am J Surg 2009;198:607-10.
20. Mastoraki A, Kriaras I, Douka E, et al. Methicillin-resistant Staphylococcus aureus preventing strategy in cardiac surgery. Interact Cardiovasc Thorac Surg 2008;7:452-6. (Pubitemid 351769080)
21. Jog S, Cunningham R, Cooper S. Impact of preoperative screening for methicillin-resistant Staphylococcus aureus by real-time polymerase chain reaction in patients undergoing cardiac surgery. J Hosp Infect 2008;69:124-30.
22. Muder RR, Cunningham C, McCray E, et al. Implementation of an industrial systems-engineering approach to reduce the incidence of methicillin-resistant Staphylococcus aureus infection. Infect Control Hosp Epidemiol 2008;29:702-8.
23. Schulz M, Nonnenmacher C, Mutters R. Cost-effectiveness of rapid MRSA screening in surgical patients. Eur J Clin Microbiol Infect Dis 2009;28:1291-6.